SCHEDULE

Friday, May 21st

08:30 - 08:35 Opening Remarks 

Session 4

Chronic myeloid leukemia

Moderator: Dr. Tsila Zuckerman

08:35 - 08:55 Genomically guided therapy for CML: are we ready?  

                         Dr. Tim Hughes

08:55 - 09:20 Open problems in CML therapy

                         Sponsored by Novartis (indpendent sponsorship)

                         Dr. Giuseppe Saglio 

09:20 - 09:30 Q&A panel

09:30 - 09:40 Coffee break 

Session 5

In the era of COVID-19…

Moderator: Dr. Dafna Yahav

09:40 - 10:05 When corona meets hematology in a world of moving targets …

                         Dr. Pia Raanani

10:05 - 10:30 EXO-CD24: Promise in the corona age – the road from an idea to a                                               groundbreaking reality

                         Dr. Nadir Arber

10:30 - 10:50 Scientific journals in corona times

                         Dr. Leonard Leibovici

10:50 - 11:05 Q&A panel

11:05 - 11:25 Special Lecture: Balancing thrombotic and bleeding risk in high-risk cancer                                patients not eligible for clinical trials

                        Dr. Avi Leader

11:25 - 11:45 Coffee break

Session 6

Molecular Oncology – from bench to bedside

Moderator: Dr. Galit Granot

11:45 - 12:05 Myeloid neoplasms with eosinophilia

                         Dr. Nick Cross

12:05 - 12:25 Critical appraisal of evidence based medicine

                         Dr. Uri Rozovski

12:25 - 12:45 RNA Therapeutics: from gene silencing to gene editing

                         Dr. Dan Peer

12:45 - 13:00 Q&A panel

13:00 - 13:25 Special Lecture: Ethical dilemmas of development and prioritization in a                                      vaccinating world 

                        Rabbi Yuval Cherlow

13:25 - 13:30 Closing Remarks 

לוגו אוניברסיטת תל-אביב.png
איגוד ההמטולוגיה.jpg
logo_belinson.jpg
האגודה למלחמה בסרטן.jpg
מרכז דוידוף.jpg